Unveiling the Clinical Path of Microinvasive Breast Cancer: A Comparative Study With Tis-T1 Breast Cancer.

Cancer Med · 2024 · PMC11462587 · PMID 39382213

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, compared to patients with CIS or T1a tumors who did not receive chemotherapy or targeted therapy, patients with MIBC still showed a trend of higher LR, suggesting the characteristics of the MIBC entity.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.